Debt-to-equity in % of XBiotech Inc. from Q3 2015 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
XBiotech Inc. quarterly Debt-to-equity history and change rate from Q3 2015 to Q3 2025.
  • XBiotech Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 0 %, a 34.9% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

XBiotech Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 0 -0 -34.9% 30 Sep 2025
Q2 2025 0 0 +6.5% 30 Jun 2025
Q1 2025 0 +0 +81.6% 31 Mar 2025
Q4 2024 0 +0 +2.2% 31 Dec 2024
Q3 2024 0 +0 +2% 30 Sep 2024
Q2 2024 0 +0 +1.5% 30 Jun 2024
Q1 2024 0 +0 +58.4% 31 Mar 2024
Q4 2023 0 0 +4.4% 31 Dec 2023
Q3 2023 0 0 -3.7% 30 Sep 2023
Q2 2023 0 0 -4.7% 30 Jun 2023
Q1 2023 0 +0 +49.9% 31 Mar 2023
Q4 2022 0 +0 +67.7% 31 Dec 2022
Q3 2022 0 +0 +79.9% 30 Sep 2022
Q2 2022 0 +0 +64% 30 Jun 2022
Q1 2022 0 0 -16.8% 31 Mar 2022
Q4 2021 0 -0 -41.4% 31 Dec 2021
Q3 2021 0 -0 -71.9% 30 Sep 2021
Q2 2021 0 -0 -73.9% 30 Jun 2021
Q1 2021 0 -0 -63.7% 31 Mar 2021
Q4 2020 0 -0 -62.2% 31 Dec 2020
Q3 2020 0 0 +9.5% 30 Sep 2020
Q2 2020 0 +0 +9.6% 30 Jun 2020
Q1 2020 0 0 +1.3% 31 Mar 2020
Q4 2019 0 +0 +38.6% 31 Dec 2019
Q3 2019 0 0 +0.62% 30 Sep 2019
Q2 2019 0 +0 +10.4% 30 Jun 2019
Q1 2019 0 +0 +17.2% 31 Mar 2019
Q4 2018 0 0 -7.8% 31 Dec 2018
Q3 2018 0 -0 -37.1% 30 Sep 2018
Q2 2018 0 -0 -43.1% 30 Jun 2018
Q1 2018 0 -0 -49% 31 Mar 2018
Q4 2017 0 -0 -43.7% 31 Dec 2017
Q3 2017 0 -0 -10.1% 30 Sep 2017
Q2 2017 0 +0 +20.4% 30 Jun 2017
Q1 2017 0 +0 +1.2% 31 Mar 2017
Q4 2016 0 +0 +1.3% 31 Dec 2016
Q3 2016 0 +0 +1% 30 Sep 2016
Q2 2016 0 30 Jun 2016
Q1 2016 0 31 Mar 2016
Q4 2015 0 31 Dec 2015
Q3 2015 0 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.